- The Human Genome Project (HGP) was
an international collaborative program whose goal was to complete
mapping of all genes in the human genome. This concerted public
effort aimed at sequencing all the 3 billion bases of the human
DNA. The secondary goal was to provide enough information to the
researchers regarding the molecular and genetic mechanisms
underlying human diseases, such that novel strategies for
diagnosis, treatment and prevention can be invented. The objectives
towards the primarey goal are listed below:
- Sequencing the human genome in
entirety and store this information in accessible databases
- Identifying the unknown human
genes
- Mapping variations across the human
genomes
- Sequencing of the genomes of mouse
and four other model organisms.
- Develop tools for data analysis and
adress the ethical, social and legal issues.
- The support and funding from DOE
and NIH and later from the Medical Research Council and Wellcome
Trust in UK enabled the project to run over 13 years on a huge
scale, ending up with a cost of 3 billion dollars. In total, the
Human Genome Project team or the ‘International Human Genome
Sequencing Consortium’ involved scientists from 20 institutions
across six countries: France, Germany, Japan, China, the UK and the
USA. But the main institutions which sequenced majority of the
genome, also nicknamed as G5, were:
- Broad Institute/Whitehead Institute
for Biomedical Research (MIT), Cambridge, USA
- Baylor College of Medicine,
Houston, USA
- Department of Energy’s Joint Genome
Institute, Walnut Creek, USA
- Washington University, St Louis,
USA
- Wellcome Trust Sanger Institute,
Cambridge, UK
This project of international
interest had several federal agencies from US involved. 1) National
Institute of Health (NIH), 2) Centers for Disease Control and
Prevention (CDC), 3) Department of Energy (DOE), 4) Food and Drug
Administration (FDA), 5) NIH Office of Biotechnology Activities
(OBA), 6) Health Resources and Services Administration (HRSA), 7)
National Science Foundation (NSF), 8) United States Department of
Agriculture (USDA).
Additionally, the European
Bioinformatics Institute in Cambridge, UK, and the National Centre
for Biotechnology Information at the US National Institutes of
Health provided the computational and analytical support for
assembly of the gene sequences across the chromosomes.
- The Human Genome Project started in
1990 and was completed successfully in April 2003. This project for
a period of 13 years and costing 3 billion dollars, was completed
successfully under budget and two years before schedule. The
proposal for sequencing the human genome was laid down in 1985,
following which the Human Genome Organisation (HUGO) was founded in
1988. In 1990, the project is launched with James Watson of the
famous Watson-Crick pair as the director. In 1996, the
representatives of the various sequencing centres meet at Bermuda
to set down the Bermuda principles that laid down the draft of
principles for rapid and free access to the human genome. In 1999,
large scale DNA sequencing of the human genome begins and in that
year itself, the the sequence of the first human chromosome,
chromosome 22, is completed. In 2000, the University of California,
Santa Cruz, launches its Human Genome Browser. The first draft of
the human genome was published by the International Human Genome
Sequencing Consortium in February 2001 in the jounal
Nature. In 2003, the "gold standard" official human genome
is completed to 99.99 % accuracy.
- Some of the important techniques
used in the HGP are:
- DNA Sequencing
- Restriction Fragment Length
Polymorphism (RFLP)
- Yeast Artificial Chromosomes
(YAC)
- Bacterial Artificial Chromosomes
(BAC)
- Polymerase chain reaction
(PCR)
- Electrophoresis
- Computational tools to assemble the
data and analyse it.
- The HGP revealed that probably
there are 20,500 genes which appeared to be significantly fewer
than previous estimates, which ranged from 50,000 genes to as many
as 140,000. HGP has also revealed the non-coding regions of the
DNA, leading to the realisation that majority of the DNA is
actually junk and does not lead to any gene products . However the
significance of this remains to be elucidated. The HGP has led to
the discovery of approximately 1800 disease related genes and has
contributed largely in the development of the field of
pharmacogenomics.
- The HGP also involved genome
sequencing of model organisms. This is of significance as a
comparative genomics between genomes of humans and model organisms
paves the path to understand evolution from the common ancestor,
how a genome accumulated variations, and gives us an idea about how
we evolved. It also gives us an hint about why are we suscetible or
resistant to certain diseases when a overall comparison of
homologous genes in human and model organisms are done.
- Accomplishments and Challenges
following the HGP.
- The HGP increased the credibility
of genetic screening and DNA based tests, offering detection of
several diseases at a time, allowing quick diagnosis and follow up
treatment, and also aids in detection of carrier in families and
the likelihood of an individual in developing the disease.
- Targeted drug and immuno therapies
have found a new dimension with the onset of HGP. Understanding the
genetic variation between individuals can help us understand how
certain individuals are susceptible or resistant to certain
diseases. Additionally, the HGP helped in gene therapy techniques,
leading to proper identification and replacement of defective
genes.
- The HGP also led to the initiation
of several other sequencing projects involving other microbes,
cancer, single nucleotide polymorphisms, which allowed researchers
to work with specific areas of interest. Other offshoot areas of
research like anthropological studies of populations and migration
patterns, arised from the HGP
- After 10-15 years post the HGP,
researchers identified challenges involved with the HGP. 1)
Although the HGP 's broader objective was to improve human health,
it does raise of the question of how is this vast amount of
information being used and interpreted, or who has access to it. 2)
If there is any improper use of genetic information, is the society
adapted to combat such issues? A fair use of gentic information in
cases of insurance, employment, adoption, criminal justice and
military is necessary. Otherwise the privacy and confidentiality of
the genetic information is at risk. 3) Commercialization of
products from genetic research raises the questions of ownership ,
leading to patents, copyright and data accessibility.
- In my opinion, the Human genome
project aimed at a better understanding of the human genome, for
broader implications in healthcare, risk assessment, and for
solving other environmental issues. However the privacy and
confidentiality of such information cannot be bargained at any
cost. Though data accessibility poses such problems, but the
information should be used only in the betterment of health care,
allowing quick diagnosis, improved treatment and employing better
preventive measures. However, discrimination in delivering
treatment on the basis of such genetic information should not be
encouraged. Rather issues of environmental problems such as waste
management, increasing agricultural produce and ensuring safe food
and drinking water quality should be strengthened.